Evogene Ltd. Insider Trading
EVGN
Insiders bought 695K on the open market and sold nothing.
Get an email when EVGN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 11 | Leon Recanati Director | Bought | 460,000 | $0.64 | 294K | 52% | Form 4 |
| Aug 4 | Leon Recanati Director | Bought | 800,000 | $0.50 | 400K | 954% | Form 4 |
| Jun 4 | Gabi Tarcic Chief Development Officer | Bought | 1,129 | $0.60 | $677 | New | Form 4 |
- Aug 11Leon RecanatiDirector · bought 460,000 at $0.64294K52% of stake
- Aug 4Leon RecanatiDirector · bought 800,000 at $0.50400K954% of stake
- Jun 4Gabi TarcicChief Development Officer · bought 1,129 at $0.60$677New position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with EVGN
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing EVGN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.